Phil Clare has joined Queen Mary Innovation as chief executive, having previously worked for University of Oxford since 2006.
Queen Mary Innovation, the commercialisation arm of Queen Mary University of London, has recruited Phil Clare as its chief executive.
Clare joins from University of Oxford where he had been director of innovation and engagement since 2006. In that role, he worked closely with tech transfer subsidiary Oxford University Innovation and venture fund Oxford Science Enterprises.
Among his achievements at Oxford was his involvement in negotiating the licence for the covid vaccine to AstraZeneca, of which more than three billion doses have been supplied to 183 countries around the world to date.
Clare has also been involved with professional organisation PraxisAuril since 2004, having been a director, chairman and, since 2019, an ambassador. He has been a member of the council of Research England since 2018.
Earlier this year, he chaired the Knowledge Exchange Concordat Evaluation Panel for UUK.
Earlier in his career, he was grants and contracts officer at University of Bath from 1996 to 1997. He joined Bournemouth University in 1998 first as a research and commercialisation manager and in 2006 stepped up to acting head of the Centre for Research and Knowledge Transfer.
Clare said: “I am looking forward to joining the experienced team at Queen Mary Innovation. Since my appointment I have received many messages congratulating me on joining such an ambitious and forward-looking university and I can’t wait to start.
“We will grow the team and look for every opportunity to work with the leading researchers at Queen Mary who want to use their technologies and innovations to make a real difference to our global economy and society, taking our researchers’ innovations from Whitechapel to the world.”